pharmaceutical research has specific characteristics which are not taken into consideration by the Community framework of aid for research-development. Indeed, pharmaceutical research can be divided into three stages which stretch over at least 10 years: the research concept phase, preclinical tests and clinical trials. The last-named stage can be subdivided in three phases, of which only the third involves tests on a significant number of persons (several thousand);
the research corresponds to 'industrial research` and 'precompetitive development activity` according to the definitions given in the 1996 State aid guidelines, since at the time of the notification the drug Orlistat was still several years away from the market.
Furthermore, the research concept phase, preclinical tests and the first two stages of the clinical trials constitute 'industrial research` not only because the drug is several years from the market, but also because of the still substantial risk that the drug will not pass the final stages of clinical testing. Also, the third stage of the clinical tests are to be regarded as 'precompetitive development activity`,
other pharmaceutical companies carry out research on anti-obesity drugs, but their procedure is different from that of Orlistat,
the 'incentive` effect is clear since HLR would not have carried out the production of 'hydoxy-beta-lactone` at CL without the prospect of receiving State aid,
finally, as regards the necessity of the aid, the Austrian authorities consider that the aid is necessary because of the high development costs, the substantial risk that the drug will not be approved for marketing, as well as the particularly innovative character of Orlistat.
Aid for environmental protection
according to the Austrian authorities, the measures of environmental protection to be implemented by HLR at the CL plant go beyond the standards required by Austrian legislation,
Austria provided further information on the eligible costs and on the economic advantages for the company arising from the implementation of the environmental measures.
As regards aid for CL personnel retraining, this subsidy constitutes a general measure, not limited to any region, sector or individual company.